Journal of Chemotherapy

Papers
(The H4-Index of Journal of Chemotherapy is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Clinical evaluation of camrelizumab combined with transarterial chemoembolization in the interventional therapy of hepatocellular carcinoma with liver cirrhosis74
Looking for Stenotrophomonas maltophilia treatment: in vitro activity of ceftazidime/avibactam alone and in combination with aztreonam52
MiR-302a-3p reduces cisplatin resistance of esophageal squamous cell carcinoma cells by targeting EphA232
Innovative sequential therapy in a rare case of refractory Erdheim-Chester disease with bilateral pulmonary involvement30
Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer22
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae21
Cytofluorimetric study of cerebrospinal fluid at staging of diffuse large B cell lymphoma17
YAP/TAZ axis was involved in the effects of metformin on breast cancer13
Comparative in vitro activities of eravacycline in combination with colistin, meropenem, or ceftazidime against various Achromobacter spp. strains isolated from patients with cystic fibrosis13
Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database12
Nivolumab-induced Lambert-Eaton myasthenic syndrome: an immune-related adverse event in nonsmall cell lung cancer12
Piperacillin/Tazobactam is associated with a higher risk of acute kidney injury compared to cefepime and meropenem12
0.1391007900238